6 – 8 June, 2023
The Gene Therapy for Neurological Disorders Summit is back as Europe’s exclusive meeting focussed on innovations in gene therapy vectors for CNS delivery, and as the only event to cover Eurocentric challenges facing gene therapy developers.
Recent years have been turbulent for the gene therapy field, but with recent approvals like Upstaza and Skysona, the future is looking bright for CNS gene therapies.
This June will see 80+ drug developers working in gene therapy for neurological disorders united with the shared goal of overcoming preclinical translatability, clinical, delivery and market access challenges to help get life changing gene therapies to patients faster in Europe.
Upload your resume
Rodendijk 60 X
2980 Zoersel, Belgium
+32 (0) 3 296 01 51
General Inquiry: email@example.com
Job Opportunities: HR@2bridge.be
Service & Solution: BD@2bridge.be
2 Bridge NV is a recognized service provider for the KMO portefeuille (SME portfolio) for providing strategic advice(DV.A222333) and training (DV.O214140).
2 Bridge obtained the Crédit Impots Recherche (CIR) Accreditation for the years 2021, 2022, and 2023, an initiative of the French government to provide tax credit for R&D services.
© 2023 2 Bridge. website by EHBOntwerp